NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Showing 1-8 of 8 articles
Interventions for valvular disease
Repeat transcatheter aortic valve replacement and implications for transcatheter heart valve performance: insights from bench testing January 26, 2021 | 10.4244/EIJ-D-20-00697
Reference dimensions of stented surgical aortic bioprostheses for valve size determination
August 7, 2020 | 10.4244/EIJ-D-19-00921
“Minimalist” transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity
August 7, 2020 | 10.4244/EIJV16I6A82
A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention
March 20, 2020 | 10.4244/EIJ-D-19-00939
Interventions for valvular disease
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions February 7, 2020 | 10.4244/EIJ-D-19-00782
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Increasing awareness of the need to protect the coronary arteries in patients with failed surgical and transcatheter aortic valves
May 20, 2019 | 10.4244/EIJV15I1A3
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935